BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients

NCT01498172 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

BIOLOGICAL: MAGE-A3 ASCI
BIOLOGICAL: BCG

Sponsor

Patrice Jichlinski

Collaborators

[object Object]
[object Object]